chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Rash erythematous
Clinical narrative: red rash on lower legs; This is a spontaneous report from a contactable consumer, the parent. A 16-years-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: Er8732) via unspecified route of administration in the right arm on 27Mar2021 at 11:30 (at the age of 16-years-old), as a single dose for COVID-19 immunisation. Medical history included asthma. The patient had known allergy to pet dander. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included fluoxetine (MANUFACTURER UNKNOWN) for unknown indication taken within two weeks of vaccination. On 28Mar2021 at 15:00, the patient experienced red rash on his lower legs. The patient did not receive any treatment for the reported event. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of red rash was unknown. No follow-up attempts are needed.   No further information expected.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Paraesthesia
Clinical narrative: Approximately 30 minutes after the vaccine administration, my face started to turn red and tingle.; Approximately 30 minutes after the vaccine administration, my face started to turn red and tingle.; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old male patient received first dose of BNT162b2 (PFIZER- BIONTECH COVID-19 m RNA vaccine, lot no: unknown) via an unspecified route of administration in left arm on 24Mar2021 at 09:30 (at the age of 30-year-old) as a single dose for COVID-19 immunisation. Medical history was not applicable. The patient had seasonal allergies to pollen. Concomitant medications were not reported. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient had not tested positive with COVID-19. The patient had not tested positive for COVID-19 since having the vaccine.  On 24Mar2021 at 10:15, the patient experienced face red and tingling, approximately 30 minutes after the vaccine administration, the patient's face started to turn red and tingle. The sensation mostly had subsided within 30 minutes after onset. But still, the patient had lingering sensation 2 hours later. The patient had not received any treatment for the adverse events. The clinical outcome of the events faces red and tingling were recovered with sequelae.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Nausea
Clinical narrative: Headache; Nausea; Chills; Fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 29-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6206), via an unspecified route of administration in the left arm on 22Mar2021 at 16:30 (at the age of 29-years-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were reported as no. The patient had no known allergies to medications, food or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 23Mar2021 at 11:00, the patient experienced headache, nausea, chills and fatigue. The patient did not receive treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events, headache, nausea, fatigue and chills was recovered on an unspecified date in Mar2021.   No follow-up attempts are possible. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Cough, Nasal congestion
Clinical narrative: Tested positive for COVID; Lost sense of taste and smell; Lost sense of taste and smell; Congestion; Dry cough; This is a spontaneous report from a contactable consumer or other non hcp.  A 29-years-old female patient received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection), via intramuscular route, administered in Arm Left on 17Mar2021 (Batch/Lot Number: EN6206; Expiration Date: 30Jun2021) as DOSE UNKNOWN, 0.3ml SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Received call from consumer regarding the Pfizer COVID vaccine. He would like to speak with someone about the effects he had, and any suggestions Pfizer may have to help him. While reporting side effects for himself, he mentioned that his wife, son and daughter, all had side effects after receiving the vaccine. father of patient handed phone to his daughter after he reported for himself. His daughter came on the line and reported on behalf of herself that, she tested positive for COVID on 22 Monday, 22Mar2021, but did not get results until yesterday 25Mar2021. This occurred after she got the vaccine. On 20Mar2021, the patient had cough, on 21Mar2021, the patient had congestion and on 22Mar2021, the patient had Lost sense of taste and smell. The patient underwent lab tests and procedures which included sars-cov-2 antibody test positive: positive on 22Mar2021. Product quality complaint was recorded for compound BNT162 COVID-19 VACCINE SUSPENSION FOR INTRAMUSCULAR 2ML MULTIPLE DOSE VIAL X 1 (not clear after first shot or second Covid positive). The clinical outcome of the events (at the time of report was) Lost sense of taste and smell was not recovered, Congestion, dry cough was recovering, tested positive for COVID was unknown.  No follow-up attempts are possible; No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 antibody test positive
Clinical narrative: Tested positive for COVID; Lost sense of taste and smell; Lost sense of taste and smell; Congestion; Dry cough; This is a spontaneous report from a contactable consumer or other non hcp.  A 29-years-old female patient received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection), via intramuscular route, administered in Arm Left on 17Mar2021 (Batch/Lot Number: EN6206; Expiration Date: 30Jun2021) as DOSE UNKNOWN, 0.3ml SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Received call from consumer regarding the Pfizer COVID vaccine. He would like to speak with someone about the effects he had, and any suggestions Pfizer may have to help him. While reporting side effects for himself, he mentioned that his wife, son and daughter, all had side effects after receiving the vaccine. father of patient handed phone to his daughter after he reported for himself. His daughter came on the line and reported on behalf of herself that, she tested positive for COVID on 22 Monday, 22Mar2021, but did not get results until yesterday 25Mar2021. This occurred after she got the vaccine. On 20Mar2021, the patient had cough, on 21Mar2021, the patient had congestion and on 22Mar2021, the patient had Lost sense of taste and smell. The patient underwent lab tests and procedures which included sars-cov-2 antibody test positive: positive on 22Mar2021. Product quality complaint was recorded for compound BNT162 COVID-19 VACCINE SUSPENSION FOR INTRAMUSCULAR 2ML MULTIPLE DOSE VIAL X 1 (not clear after first shot or second Covid positive). The clinical outcome of the events (at the time of report was) Lost sense of taste and smell was not recovered, Congestion, dry cough was recovering, tested positive for COVID was unknown.  No follow-up attempts are possible; No further information is expected.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Nausea, SARS-CoV-2 test, Vomiting
Clinical narrative: Came with a moderateheadache; Repeated nausea; vomiting from 7 am to 4 pm, could not hold anything down; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: ep7534) and expiry date included 31Jun2021, via an unspecified route of administration to left arm on 17Mar2021 at 16:00 (at the age of 62-year-old), as single dose for COVID-19 immunisation. Medical history includes paroxysmal atrial fibrillation (episodic) and unknown if ongoing. Concomitant medications include pravastatin (MANUFACTURER UNKNOWN), metoprolol (MANUFACTURER UNKNOWN) and flecainide (MANUFACTURER UNKNOWN) for an unspecified indication since an unknown date. The patient had no known allergies to foods, medications or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 20Mar2021 at 07:00 (as reported 08: 00), the patient experienced repeated nausea and vomiting from 7 am to 4 pm, could not hold anything down and came with a moderate headache at 08:00. The events resulted in doctor or other healthcare professional office/clinic visit. The patient underwent lab test on 20Mar2021 (since the vaccination) which included nasal swab test (SARS-COV-2) and the test result was negative. Therapeutic measures were not taken as a result of the events nausea, vomiting and headache. The clinical outcomes of events nausea, vomiting and headache were recovered in 20Mar2021 at 16:00 and on an unknown date in Mar2021 respectively.  No follow-up attempts are possible. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: I felt like ants were crawling on my back, neck and head. Eventually the itching besides on my back and head went to legs.; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 18Mar2021 at 08:00 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient was allergic to penicillin, sulfur, tomatoes, citrus food, sugar and milk. Concomitant medications included unspecified vitamins. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within 2 weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9267) via an unspecified route of administration in the left arm on 25Feb2021 at 10:00 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. On 20Mar2021, at 00:00 the patient felt like ants were crawling on her back, neck and head. Eventually the itching besides on her back and head went to her legs. The adverse event resulted in a Doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event itching included treatment with Allegra and Zyrtec. The clinical outcome of the event itching was not recovered at the time of the report.   No follow-up attempts are needed. No further information is expected
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site urticaria, Rash, Urticaria, Vaccination site rash
Clinical narrative: Rash at injection site; Hives at injection site; Rash all over arm; Hives all over arm; This is a spontaneous report from a contactable other healthcare professional, the patient. A 33-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unknown route of administration in left arm on 18Mar2021 at 12:15 (at an age of 33-years-old) as single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medication were not reported. The patient previously received acetaminophen(TYLENOL) on an unknown date and experienced pertussis. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. On 19Mar2021, the patient experienced rash/hives at the injection site and all over the arm. The events resulted in doctor or other healthcare professional office/clinic visit. The patient received treatment with citirizine(ZYRTEC) for the events. The clinical outcome of rash/hives at the injection site and all over the arm was recovering.  No follow-up attempts are possible; information about lot number cannot be obtained.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Headache, Peripheral swelling, Rash, Wheezing
Clinical narrative: fingers really swollen; tight chest; Wheezing; headache; Rash on body; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: ER8732) via an unspecified route of administration in the left arm on 25Mar2021 at 14:45 (at the age of 44-years-old) as single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis (RA) and celiac disease. The patient had a history of allergy to sulfamethoxazole, trimethoprim (BACTRIUM), penicillin, nitrofurantoin (MACROBID) and gluten. The patient did not take any concomitant medication. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 25Mar2021 at 15.30, the patient experienced headache within 30 minutes and rash on body that night then next day morning woke up to fingers really swollen, tight chest and wheezing. The patient received benadryl and advil as treatment advised by doctor for the reported events. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the rash, headache, finger swollen, tight chest and wheezing was not resolved.   No follow-up attempts are needed. No further information expected.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Heart rate increased, Influenza, Lip swelling, Peripheral swelling
Clinical narrative: Tinnitus; Had swelling of hands face and lips 1 hr after Pfizer shot #1; Had swelling of hands face and lips 1 hr after Pfizer shot #1; Had swelling of hands face and lips 1 hr after Pfizer shot #1; Rapid heart beat; Warmth; Flu symptoms; This is a spontaneous report from a contactable nurse, the patient. A 65-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN), via an unspecified route of administration in the right arm on 05Mar2021 at 13:15 (at the age of 65-years-old), as a single dose for COVID-19 immunisation. Medical history included sinusitis and sulfonamide allergy. Concomitant medications included OTC biotin (MANUFACTURER UNKNOWN), serenoa repens (SAW PALMETTO), cholecalciferol (VITAMIN D3) and multi vitamin (MANUFACTURER UNKNOWN); all from unknown dates for unspecified indications. The patient previously received cefaclor (CECLOR) and levofloxacin (MANUFACTURER UNKNOWN); both on unknown dates for unspecified indications and experienced drug allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 05Mar2021 at 14:15, the patient experienced swelling of hands face and lips, 1 hour after the vaccination. The patient experienced tinnitus after 2 hours which still existed after 3 weeks and rapid heartbeat, warmth and flu symptoms for 24 hours. The patient did not receive treatment for the reported events. The clinical outcome of the events swelling of hands, swelling of face and swelling of lips and tinnitus was not recovered and of the rapid heartbeat, warmth and flu symptoms was recovered on an unspecified date in Mar2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling face, Tinnitus
Clinical narrative: Tinnitus; Had swelling of hands face and lips 1 hr after Pfizer shot #1; Had swelling of hands face and lips 1 hr after Pfizer shot #1; Had swelling of hands face and lips 1 hr after Pfizer shot #1; Rapid heart beat; Warmth; Flu symptoms; This is a spontaneous report from a contactable nurse, the patient. A 65-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN), via an unspecified route of administration in the right arm on 05Mar2021 at 13:15 (at the age of 65-years-old), as a single dose for COVID-19 immunisation. Medical history included sinusitis and sulfonamide allergy. Concomitant medications included OTC biotin (MANUFACTURER UNKNOWN), serenoa repens (SAW PALMETTO), cholecalciferol (VITAMIN D3) and multi vitamin (MANUFACTURER UNKNOWN); all from unknown dates for unspecified indications. The patient previously received cefaclor (CECLOR) and levofloxacin (MANUFACTURER UNKNOWN); both on unknown dates for unspecified indications and experienced drug allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 05Mar2021 at 14:15, the patient experienced swelling of hands face and lips, 1 hour after the vaccination. The patient experienced tinnitus after 2 hours which still existed after 3 weeks and rapid heartbeat, warmth and flu symptoms for 24 hours. The patient did not receive treatment for the reported events. The clinical outcome of the events swelling of hands, swelling of face and swelling of lips and tinnitus was not recovered and of the rapid heartbeat, warmth and flu symptoms was recovered on an unspecified date in Mar2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Headache, Neck pain, Pain in extremity
Clinical narrative: Light headed; fatigue; Arm soreness; headache; neck aches; sinus congestion; This is a spontaneous report from a non-contactable other healthcare professional, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8727) via unspecified route of administration in the left arm on an unknown date (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included menstrual pain, and unknown skin disorder which was not diagnosed but it was unknown if the skin issues were possibly autoimmune related. The patient did not have any known allergies to medications, food and other products. Concomitant medication included ibuprofen (MANUFACTURER UNKNOWN) for menstrual pain started from an unknown date in Mar2021 (reported as day before vaccination). Prior to vaccination, the patient was not tested positive for COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccine 4 weeks prior to the COVID vaccine. On 25Mar2021 at 08:15, the patient experienced light headed / little dizzy after shot for about 6 hours, fatigue, arm soreness, head and neck aches, especially at base of the skull and some sinus congestion and continuing fatigue the next morning. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the reported events. The clinical outcomes of the events arm soreness was recovering at the time of this report. The clinical outcome of the event fatigue was not recovered at the reporting time; while that of the events light headed/little dizzy, headache, neck aches and sinus congestion were unknown.  No follow-up attempts are possible. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Sinus congestion
Clinical narrative: Light headed; fatigue; Arm soreness; headache; neck aches; sinus congestion; This is a spontaneous report from a non-contactable other healthcare professional, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8727) via unspecified route of administration in the left arm on an unknown date (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included menstrual pain, and unknown skin disorder which was not diagnosed but it was unknown if the skin issues were possibly autoimmune related. The patient did not have any known allergies to medications, food and other products. Concomitant medication included ibuprofen (MANUFACTURER UNKNOWN) for menstrual pain started from an unknown date in Mar2021 (reported as day before vaccination). Prior to vaccination, the patient was not tested positive for COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccine 4 weeks prior to the COVID vaccine. On 25Mar2021 at 08:15, the patient experienced light headed / little dizzy after shot for about 6 hours, fatigue, arm soreness, head and neck aches, especially at base of the skull and some sinus congestion and continuing fatigue the next morning. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the reported events. The clinical outcomes of the events arm soreness was recovering at the time of this report. The clinical outcome of the event fatigue was not recovered at the reporting time; while that of the events light headed/little dizzy, headache, neck aches and sinus congestion were unknown.  No follow-up attempts are possible. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Nausea, Pain, Vaccination site pain
Clinical narrative: body aches; dizziness; pain at injection site; nausea; exhaustion; This is a spontaneous report from a non-contactable other healthcare professional, the patient. A 41-year-old non pregnant female patient received second dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Lot number; ER2613), via an unspecified route of administration in Left arm on 25Mar2021 at 13:30 (at the age of 41 years) as single dose for COVID-19 immunisation. Medical history was reported as none. Concomitant medications were not reported. The patient had no known allergies. The patient previously received first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Lot number; EN6203), via an unspecified route of administration in Left arm on 04Mar2021 at 13:00 (at the age of 41 years) as single dose for COVID-19 immunisation Prior to vaccination, patient was not diagnosed with COVID-19; Since the vaccination, patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received unspecified medications within 2 weeks of vaccination. On 26Mar2021 at 01:00, patient experienced body aches, pain at injection site, nausea, dizziness and exhaustion. Therapeutic measures were taken as a result of adverse event included ibuprophen. The adverse event did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the event body aches, pain at injection site, nausea, dizziness and exhaustion was recovered on an unknown date at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Menstruation delayed
Clinical narrative: This is a spontaneous report received from a contactable consumer, the patient. A 43-year-old non pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route in left arm on 17Mar2021 at 15:30 (at an age of 43 years), as a single dose for COVID-19 immunisation. Patient has no medical history. The patient did not have any allergies to medications, food, or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 22Mar2021, the patient experienced thrown off menstrual cycle which never occurred in the past. The patient did not receive treatment for events. The events had not resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of event menstrual cycle thrown off was unknown at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Headache, Pain, Viral test
Clinical narrative: This is a spontaneous report received from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the right arm on 23Mar2021 at 09:00 (at the age of 39-years-old), as a single dose for COVID-19 immunisation. The patients medical history and concomitant medications were not reported. Other vaccines received within four weeks prior to the COVID-19 vaccine was reported as no. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. On 23Mar2021, the patient had undergone nasal swab test and the result was pending. On 23Mar2021 at 22:30, patient experienced general body pain (body ache), joint pain, headache and chills. No treatment was received for the adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the general body pain (body ache), joint pain, headache and chills was not resolved at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache
Clinical narrative: Headache; Joint pain; Extreme fatigue; Chills; This is spontaneous report from non-contactable consumer, the patient. A 48-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 25Mar2021 at 13:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included eczema, idiopathic intracranial hypertension and asthma. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN), diphenhydramine hydrochloride (BENADRYL), furosemide (LASIX) and levocetirizine dihydrochloride (XYZAL) for an unknown indication. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 25Mar2021 at 17:45, the patient had experienced headache, joint pain, extreme fatigue and chills. Adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken for the reported events. The clinical outcome of the events headache, joint pain, extreme fatigue and chills was resolving at the time of report.  Information about lot/batch number cannot be obtained. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Arthralgia, Blood pressure increased, Blood pressure measurement, Heart rate
Clinical narrative: pain in elbow of right arm; Pain in fingers/knuckles of right arm; Anxiety level increased; Heart rate went to 101; blood pressure skyrocketed to 142/88; Throat started closing; This is a spontaneous report from a contactable consumer, the patient. A 29-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number UNKNOWN) via an unspecified route of administration in the right arm on 25Mar2021 at 14:45 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient received codeine (MANUFACTURER UNKNOW) for unspecified indication on unknown date and she experienced drug allergy to it. Concomitant medications included ethinylestradiol; norgestimate (SPRINTEX), bifidobacterium bifidum; bifidobacterium lactis; bifidobacterium longum; cactobacillus acidophilus; cactobacillus rhamnosus (PROBIOTIC) and colecalciferol (VITAMIN D3), all were for unspecified indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19 on an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 25Mar2021 at 15:15, the patient experienced pain in elbow and fingers/knuckles of right arm. After about 20-25 min throat started closing, anxiety level increased. Heart rate was 101 and blood pressure skyrocketed to 142/88. The patient underwent COVID-19 antigen test on 25Mar2021 and the result was negative. The events resulted in doctor or other healthcare professional office/clinic visit. The therapeutic measures included treatment with benadryl for all the event from an unknown date. The clinical outcome of pain in elbow and fingers, anxiety, heart rate increased, blood pressure increased and throat constriction was recovering at the time of report.  No follow-up attempts are possible; information about lot number cannot be obtained.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased, Pain in extremity, SARS-CoV-2 test, Throat tightness
Clinical narrative: pain in elbow of right arm; Pain in fingers/knuckles of right arm; Anxiety level increased; Heart rate went to 101; blood pressure skyrocketed to 142/88; Throat started closing; This is a spontaneous report from a contactable consumer, the patient. A 29-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number UNKNOWN) via an unspecified route of administration in the right arm on 25Mar2021 at 14:45 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient received codeine (MANUFACTURER UNKNOW) for unspecified indication on unknown date and she experienced drug allergy to it. Concomitant medications included ethinylestradiol; norgestimate (SPRINTEX), bifidobacterium bifidum; bifidobacterium lactis; bifidobacterium longum; cactobacillus acidophilus; cactobacillus rhamnosus (PROBIOTIC) and colecalciferol (VITAMIN D3), all were for unspecified indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19 on an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 25Mar2021 at 15:15, the patient experienced pain in elbow and fingers/knuckles of right arm. After about 20-25 min throat started closing, anxiety level increased. Heart rate was 101 and blood pressure skyrocketed to 142/88. The patient underwent COVID-19 antigen test on 25Mar2021 and the result was negative. The events resulted in doctor or other healthcare professional office/clinic visit. The therapeutic measures included treatment with benadryl for all the event from an unknown date. The clinical outcome of pain in elbow and fingers, anxiety, heart rate increased, blood pressure increased and throat constriction was recovering at the time of report.  No follow-up attempts are possible; information about lot number cannot be obtained.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Pain, Pain in extremity
Clinical narrative: Sore arm; headache; slight nausea; body ache; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3247), via an unspecified route of administration in the right arm on 25Mar2021 at 10:45 (at the age of 67-years-old), as a single dose for COVID-19 immunisation. Medical history included gluten sensitivity. Concomitant medications included multivitamin (MANUFACTURER UNKNOWN), vitamin d nos (MANUFACTURER UNKNOWN) and psyllium hydrophilic mucilloid (METAMUCIL); all from unknown dates for unspecified indications. The patient did not receive other vaccines within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 25Mar2021, the patient experienced sore arm, headache, slight nausea and body ache which lasted approximately 24 hours. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the events sore arm, headache, slight nausea and body ache. The clinical outcome of the events sore arm, headache, slight nausea and body ache was recovered on an unspecified date in Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: headache since vaccine; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6198), via an unspecified route of administration in the right arm on 16Mar2021 at 09:00 (at the age of 44-years-old), as a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. On 16Mar2021, the patient experienced headache since the vaccination. The patient did not receive any treatment for the headache. The event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the headache was not recovered at the time of reporting.  No follow-up attempts are needed. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Fatigue, Headache, Pain
Clinical narrative: Chills; achy; extremely tired; loose bowels; head ache; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 24Mar2021 at 13:30 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included high cholesterol and hypothyroidism (reported as thyroid hypo). The patient did not had allergy to any medications, food, or other products. The patient received unspecified concomitant medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 27Mar2021 at 05:00, the patient experienced chills, achy, extremely tired, loose bowels, and headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for reported events. The clinical outcome of the events chills, achy, extremely tired, loose bowels and headache were recovered with sequelae on an unknown date in Mar2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chest pain, Insomnia
Clinical narrative: Extreme joint pain lasting; Chest painful with every breath; Could not sleep even; This is a spontaneous report from a non-contactable consumer, the patient. A 60-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN), via an unspecified route of administration in the right arm on 11Mar2021 at 13:30 (at the age of 60-years-old), as a single dose for COVID-19 immunisation. Medical history included lung cancer and diabetes. The patient did not have allergies to medications, food, or other products. Concomitant medications included chemoradiation, metformin (MANUFACTURER UNKNOWN), rosuvastatin (MANUFACTURER UNKNOWN) and omeprazole (MANUFACTURER UNKNOWN); all taken for unknown indication from an unknown date. The patient had not received any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 11Mar2021 at 15:00, the patient experienced extreme joint pain which lasted for 15 hours. The patient also experienced chest pain with every breath and was not able to sleep with Tylenol PM, had to sit up in the chair for five hours, could not stand pain lying down and hence took 3 more Tylenol regular strength 4 hours after first dose. The chest pain then moved to neck area lasted rest of the day with Tylenol helped. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of joint pain, chest pain, sleep difficult and included treatment with TYLENOL. The clinical outcomes of the events joint pain, sleep difficult and chest pain was resolved in Mar2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous, Rash pruritic
Clinical narrative: Itchy red rash from neck down to groin.; red rash/hives from neck down to groin.; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via unspecified route of administration in left arm on 22Mar2021 at 15:30 (at the age of 36-year-old) as single dose for COVID-19 immunisation. Medical history was not reported. The patient experienced allergy to sulfa drugs. The concomitant medication included probiotics (MANUFACTURER UNKNOWN) and collagen (MANUFACTURER UNKNOWN) for unknown indication. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 26Mar2021 at 08:00, the patient experienced itchy red rash and hives from neck down to groin. The patient had received antihistamine as the treatment for reported adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events Itchy red rash from neck down to groin and red rash/hives from neck down to groin were recovering at the time of this report.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Neck pain, Vaccination site pain
Clinical narrative: Intense neck pain; Upper back pain; soreness in the arm where I received the vaccine.; This is a spontaneous report from a contactable consumer, the patient. A 20-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: ER8732), via an unspecified route of administration in the left arm on 28Mar2021 at 14:45 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had not received any concomitant medications within 2 weeks of vaccine. The patient had no known allergies to medications, food, or other products. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 29Mar2021 at 08:30, the patient woke up with intense neck and upper back pain, in addition to soreness in the arm where he received the vaccine in the next morning. That was still ongoing. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures and treatments were not taken as the result of adverse events. The clinical outcome of neck pain, upper back pain and vaccination site pain was not resolved.   No follow-up attempts are needed. No further information is expected.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Visual field defect, Visual impairment
Clinical narrative: Full loss of peripheral vision left eye-narrow band can see high tips of fingers and bottom of hand a little before the full palm; 24 Hours after injection, dark spots in peripheral vision left eye; This is a spontaneous report from a contactable consumer reporting for himself. A 51-Year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number: en6207 and expiry date was not reported), via intramuscular route of administration, in Arm left, on 25Mar2021 at 10:30 AM (at the age of 51 years), as a single dose for covid-19 immunization. The patient medical history was reported as none and concomitant medications received within 2 weeks of vaccination included Aspirin day of injection. The most recent COVID-19 vaccine was administered in Hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient had no Allergies to medications, food, or other products. On 26Mar2021 at 08:00 am, the patient experienced peripheral vision defective and spots before eyes. It was reported, on 26Mar2021 at 08:00 AM, 24 Hours after injection, dark spots in peripheral vision left eye. As of today, 29Mar2021-full loss of peripheral vision left eye-Narrow band can see high tips of fingers and bottom of hand a little before the full palm. There was no treatment received for adverse events. Outcome of the events was not resolved.  No follow-up attempts are needed. No further information is expected.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Nausea, Presyncope
Clinical narrative: dizziness; lightheadedness; Nearly fainted.; nausea and the feeling may vomit,; This is a spontaneous report from a contactable consumer, the patient. A 26-years-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: er8730) via an unspecified route of administration in the left arm on 26Mar2021 at 04:00 (at the age of 26-years) as a single dose for COVID-19 immunisation. Medical history included factor V Leiden and non-diabetic hypoglycaemia. The patient had no known allergies. Concomitant medications included salicylamide, caffeine, acetylsalicylic acid (EXCEDRIN) and loperamide hydrochloride (IMODIUM) for an unknown indication. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination the patient had not been diagnosed with COVID-19. Since having the vaccine, the patient had not been tested for COVID-19. On 26Mar2021, 15 mins after vaccination, the patient experienced severe dizziness, light-headedness and nearly fainted. This sensation came in waves for 2-3 hours, usually accompanied by nausea and the feeling that the patient may vomit, though never did. The patient reported that he still feels slightly lightheaded several days later. The patient did not receive any treatments for the events. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care The clinical outcome of the dizziness, light headedness, near fainting and nausea were recovered with lasting effects at the time of this report.    No follow-up attempts are needed. No further information is expected.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Paraesthesia
Clinical narrative: Tingling in fingers; Headache for a week.; This is a spontaneous report from a contactable consumer. A 53-years old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown), via an unspecified route of administration in left arm on 19Mar2021 at 15:45 (at the age of 53-years old) as a single dose for COVID-19 immunisation. Medical history included diabetes. Allergies to medications, food, or other products was unknown. Concomitant medication included Metformin (MANUFACTURER UNKNOWN) within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient was not tested for COVID-19. On 20Mar2021, the patient experienced tingling in fingers and headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic treatment received for the events. The clinical outcome of the events tingling of extremities and headache was not recovered at the time of this report.    Information about lot/batch number cannot be obtained. No further information is expected.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Tinnitus in both ears; This is a spontaneous report received from a contactable consumer, the patient. A 42-year-old male patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Em9809) via an unspecified route of administration in the right arm on 28Feb2021 at 09:30 (at the age of 42-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to food, medications, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19.  The patient did not receive any concomitant medication within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient had not tested for COVID-19. On 23Mar2021, the patient experienced tinnitus in both ears, it was reported that the patient did not have any noise exposure. The event resulted in doctor or other healthcare professional office/clinic visit. It was unknown if the patient had received any treatment for the event experienced. The clinical outcome of the event tinnitus was unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.